--- title: "Claritev | 10-K: FY2025 Revenue Beats Estimate at USD 965.41 B" type: "News" locale: "en" url: "https://longbridge.com/en/news/277029212.md" datetime: "2026-02-26T11:17:52.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/277029212.md) - [en](https://longbridge.com/en/news/277029212.md) - [zh-HK](https://longbridge.com/zh-HK/news/277029212.md) --- # Claritev | 10-K: FY2025 Revenue Beats Estimate at USD 965.41 B Revenue: As of FY2025, the actual value is USD 965.41 B, beating the estimate of USD 960.09 M. EPS: As of FY2025, the actual value is USD -17.29, missing the estimate of USD -16.2332. EBIT: As of FY2025, the actual value is USD 419.23 B. #### Segment Revenue ##### Claims Intelligence Solutions Revenue In 2025, Claims Intelligence Solutions generated $639,861 thousand in revenue, marking a 0.8% increase compared to 2024, primarily driven by Data iSight and Financial Negotiation services, partially offset by a decrease in Surprise Bill Services due to client and program attrition. The revenue breakdown for 2025 included PSAV at $578,121 thousand, PEPM at $41,991 thousand, and Other at $19,749 thousand. For 2024, revenue was $634,767 thousand, an increase of 1.4% from 2023, with PSAV at $584,760 thousand, PEPM at $37,603 thousand, and Other at $12,404 thousand. In 2023, the segment reported $625,754 thousand in revenue, with PSAV at $591,605 thousand, PEPM at $29,396 thousand, and Other at $4,753 thousand. ##### Network Solutions Revenue Network Solutions revenue in 2025 was $206,685 thousand, an 11.6% increase over 2024, mainly due to an $18.0 million one-time revenue from a newly established channel partner in the Property and Casualty service line. The 2025 revenue consisted of PSAV at $114,249 thousand, PEPM at $47,149 thousand, and Other at $45,287 thousand. In 2024, revenue decreased by -17.1% to $185,281 thousand compared to 2023, with PSAV at $127,983 thousand, PEPM at $50,012 thousand, and Other at $7,286 thousand. For 2023, the segment’s revenue was $223,394 thousand, comprising PSAV of $158,989 thousand, PEPM of $56,809 thousand, and Other of $7,596 thousand. ##### Payment and Revenue Integrity Solutions Revenue Payment and Revenue Integrity Solutions recorded $118,867 thousand in revenue for 2025, a 7.5% increase from 2024, driven primarily by growth in Clinical Review and Payment Accuracy solutions, partially offset by a decrease in Revenue Integrity solutions. The 2025 revenue included PSAV of $118,355 thousand and PEPM of $512 thousand. In 2024, revenue was $110,576 thousand, a -1.6% decrease from 2023, with PSAV at $110,110 thousand and PEPM at $466 thousand. The 2023 revenue totaled $112,376 thousand, with PSAV at $111,962 thousand and PEPM at $414 thousand. #### Total Revenue Total revenue for Claritev Corporation in 2025 reached $965,413 thousand, representing a 3.7% increase compared to 2024. In 2024, total revenue was $930,624 thousand, a -3.2% decrease from 2023. Total revenue for 2023 was $961,524 thousand. #### Operational Metrics (Company-wide) ##### Costs of Services Costs of services increased to $253,411 thousand in 2025, up 5.9% from $239,404 thousand in 2024, mainly due to a $5.7 million rise in compensation expense and a $3.2 million increase in access and bill review fees. In 2024, costs of services were $239,404 thousand, a 1.7% increase from $235,468 thousand in 2023. ##### General and Administrative Expenses General and administrative expenses significantly increased by 46.8% to $221,518 thousand in 2025 from $150,891 thousand in 2024, primarily due to $45.0 million in Vision 2030 transformation costs, $16.9 million in antitrust-related legal costs, and a $7.2 million increase in stock compensation. For 2024, these expenses were $150,891 thousand, a 5.4% increase from $143,182 thousand in 2023. ##### Operating Income (Loss) Claritev Corporation reported an operating income of $28,765 thousand in 2025. This follows an operating loss of - $1,389,931 thousand in 2024 and an operating income of $161,982 thousand in 2023. #### Cash Flow ##### Net Cash Flows Provided by (Used in) Operating Activities Net cash flows provided by operating activities were $117,324 thousand in 2025, $107,616 thousand in 2024, and $171,720 thousand in 2023. ##### Net Cash Flows Provided by (Used in) Investing Activities Net cash flows used in investing activities were - $121,018 thousand in 2025, - $118,123 thousand in 2024, and - $249,792 thousand in 2023. ##### Net Cash Flows Provided by (Used in) Financing Activities Net cash flows provided by (used in) financing activities were $2,363 thousand in 2025, - $41,315 thousand in 2024, and - $180,993 thousand in 2023. ##### Net Decrease in Cash, Cash Equivalents and Restricted Cash The net decrease in cash, cash equivalents, and restricted cash was - $1,331 thousand in 2025, - $51,822 thousand in 2024, and - $259,065 thousand in 2023. #### Unique Metrics ##### Medical Charges Processed and Potential Savings by Category For Commercial Health Plans, medical charges processed were $86.5 billion in 2025, $80.2 billion in 2024, and $75.1 billion in 2023, with potential medical cost savings of $23.2 billion, $23.2 billion, and $21.7 billion respectively. The potential savings as a percentage of charges were 26.8% in 2025, 28.9% in 2024, and 28.9% in 2023. For Payment & Revenue Integrity, Property & Casualty, and Other, medical charges processed were $93.3 billion in 2025, $97.4 billion in 2024, and $93.6 billion in 2023, with potential medical cost savings of $1.8 billion, $1.4 billion, and $1.3 billion respectively. The potential savings as a percentage of charges were 1.9% in 2025, 1.4% in 2024, and 1.4% in 2023. Total medical charges processed amounted to $179.8 billion in 2025, $177.6 billion in 2024, and $168.7 billion in 2023. Total potential medical cost savings were $25.0 billion in 2025, $24.6 billion in 2024, and $23.0 billion in 2023. The total potential savings as a percentage of charges were 13.9% in 2025, 13.9% in 2024, and 13.6% in 2023. ##### Client Concentration Two clients accounted for 29.2% and 10.4% of Claritev Corporation’s total revenues for the year ended December 31, 2025, respectively. In the prior year, two clients accounted for 27.7% and 15.9% of total revenues for the year ended December 31, 2024. #### Outlook / Guidance Claritev Corporation’s Vision 2030 strategic plan focuses on enhancing core offerings, accelerating product expansion, entering new geographic markets, and achieving financial and operational excellence. The company has branded 2025 as “THE TURN,” emphasizing year-over-year revenue growth. Looking ahead, 2026 is branded as “THE WAY UP,” with a focus on sustaining company momentum across all aspects of Vision 2030. ### Related Stocks - [CTEV.US](https://longbridge.com/en/quote/CTEV.US.md) ## Related News & Research - [Claritev Stockholders OK Directors, PwC and Pay Plan at 2026 Virtual Annual Meeting](https://longbridge.com/en/news/284957074.md) - [Skyline Bankshares GAAP EPS of $0.82, revenue of $15.5M](https://longbridge.com/en/news/284213761.md) - [Palo Alto Networks to Announce Fiscal Third Quarter 2026 Financial Results on Tuesday, June 2, 2026 | PANW Stock News](https://longbridge.com/en/news/284897633.md) - [Veeva Systems Set to Join S&P 500 | DVN Stock News](https://longbridge.com/en/news/284845749.md) - [Are Wall Street Analysts Bullish on Mondelez International Stock?](https://longbridge.com/en/news/284759973.md)